ALS Limited (ASX:ALQ – Get Free Report) insider Nigel Garrard acquired 2,750 shares of the firm’s stock in a transaction that occurred on Friday, June 28th. The shares were bought at an average price of A$14.40 ($9.60) per share, with a total value of A$39,594.50 ($26,396.33).
Nigel Garrard also recently made the following trade(s):
- On Thursday, May 23rd, Nigel Garrard bought 4,550 shares of ALS stock. The stock was bought at an average price of A$13.97 ($9.31) per share, for a total transaction of A$63,572.60 ($42,381.73).
ALS Stock Performance
The company has a debt-to-equity ratio of 111.05, a current ratio of 0.96 and a quick ratio of 1.35.
ALS Increases Dividend
About ALS
ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, and the Americas. It operates in two segments, Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies.
Featured Stories
- Five stocks we like better than ALS
- Best Stocks Under $10.00
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Election Stocks: How Elections Affect the Stock Market
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Which Wall Street Analysts are the Most Accurate?
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for ALS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALS and related companies with MarketBeat.com's FREE daily email newsletter.